Adverse events
Adverse Events refer to any undesirable experiences associated with the use of a medical product in a patient. The concept of adverse events is critical in pharmacovigilance, clinical trials, and patient safety initiatives.
Definition[edit | edit source]
An adverse event (AE) is any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have a causal relationship with this treatment. An adverse event can therefore be any unfavorable and unintended sign (including an abnormal laboratory finding), symptom, or disease temporally associated with the use of a medicinal (investigational) product, whether or not related to the product.
Classification[edit | edit source]
Adverse events can be classified into two broad categories: serious adverse events and non-serious adverse events. Serious adverse events are those that result in death, are life-threatening, require hospitalization or prolongation of existing hospitalization, result in disability or incapacity, or are a congenital anomaly or birth defect. Non-serious adverse events are any other events that do not meet the definition of a serious adverse event.
Reporting[edit | edit source]
The reporting of adverse events is a key component of pharmacovigilance and provides the data necessary for the understanding of the risk-benefit profile of drugs. In many countries, healthcare professionals are required to report suspected adverse events to the national health authority. In addition, many pharmaceutical companies have systems in place to capture all adverse events reported to them by healthcare professionals and patients.
Prevention and Management[edit | edit source]
Prevention and management of adverse events involve a range of activities, including patient education, monitoring of patients, and use of strategies to mitigate risk. The choice of strategy depends on the nature of the adverse event, the drug involved, and the patient's individual risk factors.
See Also[edit | edit source]
This patient safety related article is a stub. You can help WikiMD by expanding it.
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD